+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Insulin Pens Market - Global Outlook & Forecast 2022-2027

  • ID: 5562648
  • Report
  • March 2022
  • Region: Global
  • 260 Pages
  • Arizton
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Insulin Pens Market Report





There will be an increase in demand for Insulin Pens in the forecast period due to its long-term cost-effectiveness and other advantages such as accuracy, better convenience, and ease of use over conventional insulin pens. Other than high-income countries with full diabetes insurance coverage, several middle-income countries have started adopting it with advanced technologies. In some countries in Europe, for example, France, Spain, and Germany, doctors highly prescribe insulin pens under the health insurance coverage with a reasonable cutting cost, which makes it more cost-effective than insulin syringes.

The insulin pens market is expected to grow at a CAGR of 6.26% during the forecast period

GLOBAL INSULIN PENS MARKET SEGMENTATION

  • The traditional insulin pens dominated the market. However, smart insulin pens are expected to increase significantly in the forecast period across the globe.
  • Hospitals & Clinics dominated the distribution channel segment because of the easy access to insulin pens in the hospital pharmacies and thus doctors are increasingly prescribing insulin pens in both high- and low-income countries.

Segmentation by Product

  • Traditional
  • Smart

Segmentation by Usage

  • Disposable
  • Reusable

Segmentation by Distribution Channel

  • Hospitals & Clinics
  • Standalone Pharmacies
  • Online

GEOGRAPHICAL OUTLOOK

  • Europe dominated the market due to high prevalence of diabetes in the region. APAC region is expected to grow at faster rate in the forecast period with the CAGR of 7.26% because of the increase in awareness and the target population.

Segmentation by Geography

  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • North America
  • US
  • Canada
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia
  • UAE

VENDOR LANDSCAPE


The leading vendors in the insulin pen industry are Lilly, Medtronic, Novo Nordisk, and Sanofi. The market competition is solely based on quality, quantity, technology, safety, and price.

KEY VENDORS

  • Lilly
  • Medtronic
  • Novo Nordisk
  • Sanofi

OTHER PROMINENT VENDORS

  • BD
  • Biocon
  • Diamesco
  • Emperra
  • Guangzhou Medsinglong Medical Equipment
  • HK Zion Industry
  • Jiangsu Delfu Medical Device
  • Owen Mumford
  • Shanghai Umitai Medical Technology
  • Sun Medical Products
  • Suzhou Peng Ye Medical Technology Co., Ltd.
  • Triones Technology (Guangzhou)
  • Ypsomed

THE REPORT INCLUDES:


1. The analysis of the global Insulin Pens market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Insulin Pens market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the global Insulin Pens market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Frequently Asked Questions about the Insulin Pens Market

What is the estimated value of the Insulin Pens Market?

The Insulin Pens Market was estimated to be valued at $1088.4 Million in 2022.

What is the growth rate of the Insulin Pens Market?

The growth rate of the Insulin Pens Market is 6.2%, with an estimated value of $1567.1 Million by 2027.

What is the forecasted size of the Insulin Pens Market?

The Insulin Pens Market is estimated to be worth $1567.1 Million by 2027.

Who are the key companies in the Insulin Pens Market?

Key companies in the Insulin Pens Market include Lilly, Medtronic, Novo Nordisk, Sanofi, BD, Biocon, Diamesco, Emperra and HK Zion Industry.

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
8 Market Opportunities & Trends
8.1 Technological Advancements in Insulin Pens
8.2 Increased Demand for Smart Insulin Pens
8.3 Introduction of Integrated Smart Pen Systems
9 Market Growth Enablers
9.1 Rising Prevalence of Diabetes
9.2 Increased Use of Insulin Pens in Ambulatory Settings
9.3 Growth in Product Launches
10 Market Growth Restraints
10.1 Complications Associated With Insulin Pens
10.2 High Cost & Lack of Universal Insurance Coverage
10.3 Large Populations With Undiagnosed Diabetes
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Traditional Insulin Pens
12.4 Smart Insulin Pens
13 Usage
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Disposable Insulin Pens
13.4 Reusable Insulin Pens
14 Distribution Channel
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Hospitals & Clinics
14.4 Standalone Pharmacies
14.5 Online
15 Geography
15.1 Geographic Overview
15.2 Market Snapshot & Growth Engine
16 Europe
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Europe: Market by Product
16.4 Europe: Market by Usage
16.5 Europe: Distribution Channel
16.7 Key Countries
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 North America: Market by Product
17.4 North America: Market by Usage
17.5 North America: Market by Distribution Channel
17.7 Key Countries
18 Apac
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Apac: Market by Product
18.4 Apac: Market by Usage
18.5 Apac: Market by Distribution Channel
18.6 Key Countries
19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Market by Product
19.4 Latin America: Market by Usage
19.5 Latin: Market by Distribution Channel
19.6 Key Countries
20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Market by Product
20.4 Middle East & Africa: Market by Usage
20.5 Middle East & Africa: Market by Distribution Channel
20.6 Key Countries
21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
22 Key Company Profiles
22.1 Lilly
22.2 Medtronic
22.3 Novo Nordisk
22.4 Sanofi
23 Other Prominent Vendors
23.1 Bd
23.2 Biocon
23.3 Emperra GmbH E-Health Technologies
23.4 Guangzhou Medsinglong Medical Equipment
23.5 Hk Zion Industry
23.6 Jiangsu Delfu Medical Device
23.7 Owen Mumford
23.8 Pendiq
23.9 Shanghai Umitai Medical Technology
23.10 Sun Medical Products
23.11 Suzhou Peng Ye Medical Devices
23.12 Triones Technology
23.13 Ypsomed
24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations
25 Quantitative Summary
25.1 Market by Geography
25.2 Market by Product
25.3 Market by Usage
25.4 Market by Distribution Channel
25.5 North America: Market by Product
25.6 North America: Market by Usage
25.7 North America: Market by Distribution Channel
25.8 Apac: Market by Product
25.9 Apac: Market by Usage
25.10 Apac: Market by Distribution Channel
25.11 Europe: Market by Product
25.12 Europe: Market by Usage
25.13 Europe: Market by Distribution Channel
25.14 Latin America: Market by Product
25.15 Latin America: Market by Usage
25.16 Latin America: Market by Distribution Channel
25.17 Middle East & Africa: Market by Product
25.18 Middle East & Africa: Market by Usage
25.19 Middle East & Africa: Market by Distribution Channel
26 Appendix
26.1 Abbreviations

Companies Mentioned

  • Lilly
  • Medtronic
  • Novo Nordisk
  • Sanofi
  • BD
  • Biocon
  • Diamesco
  • Emperra
  • Guangzhou Medsinglong Medical Equipment
  • HK Zion Industry
  • Jiangsu Delfu Medical Device
  • Owen Mumford
  • Shanghai Umitai Medical Technology
  • Sun Medical Products
  • Suzhou Peng Ye Medical Technology Co., Ltd.
  • Triones Technology (Guangzhou)
  • Ypsomed

Methodology


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.



 

Loading
LOADING...